(Q35802104)

10 August 2017

Hormonal effects of MPV-2213ad, a new selective aromatase inhibitor, in healthy male subjects. A phase I study (English)

1 reference

10 August 2017

H Scheinin

6

0 references

author name string

O Ahokoski

1

1 reference

10 August 2017

K Irjala

2

1 reference

10 August 2017

R Huupponen

3

1 reference

10 August 2017

K Halonen

4

1 reference

10 August 2017

E Salminen

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

45

1 reference

10 August 2017

2

1 reference

10 August 2017

141-146

1 reference

Current perspectives on aromatase inhibitors in breast cancer

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873353

Arimidex: a potent and selective fourth-generation aromatase inhibitor

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873353

Aromatase inhibitors and hormone-dependent cancers

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873353

Endocrine treatment of breast cancer in women

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873353

Recent progress in development of aromatase inhibitors

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873353

Clinical use of aromatase inhibitors: current data and future perspectives

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873353

Adrenal steroid endocrinology—some unsolved problems

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873353

Specificity of Low Dose Fadrozole Hydrochloride (CGS 16949A) as an Aromatase Inhibitor

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873353

Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma

11 July 2018

1 reference

12 December 2020

Aromatase inhibition: basic concepts, and the pharmacodynamics of formestane

1 reference

12 December 2020

The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects

1 reference

12 December 2020

Open dose-finding study of a new potent and selective nonsteroidal aromatase inhibitor, CGS 20 267, in healthy male subjects

1 reference

12 December 2020

Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women

1 reference

12 December 2020

Clinical and endocrine effects of the oral aromatase inhibitor vorozole in postmenopausal patients with advanced breast cancer

1 reference

12 December 2020

Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancer

1 reference

12 December 2020

1 reference

12 December 2020

10.1046/J.1365-2125.1998.00654.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

9491826

1 reference